Reactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine Uniflu
Clinical trial NCT03789539 · UNKNOWN
Trial details
- NCT number
- NCT03789539
- Sponsor
- VA Pharma Limited Liability Company
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-02
- Primary completion
- 2018-12-02
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.